Search Results

A rare case of schizophrenia in a diagnosed patient of retinitis pigmentosa.

• Authors : Praeek, Samragyi¹ (AUTHOR); Maggu, Gaurav¹ (AUTHOR); Jaishy, Rajon¹ (AUTHOR)

Subjects: RETINITIS pigmentosa; PEOPLE with schizophrenia; GENETIC disordersIRAN

• Source: Industrial Psychiatry Journal. Nov2023, Vol. 32 Issue 3, p281-282. 2p.

Record details

Q&A WITH Molly Burke.

Subjects: RETINITIS pigmentosa; MOTIVATIONAL speakersBURKE, Molly

• Source: Maclean's. Jun2019, Vol. 132 Issue 5, p59-59. 3/4p. 1 Color Photograph.

Record details

COACHES CLASH!

Subjects: SINGING competitions; RETINITIS pigmentosa; GRAMMY Awards

• Source: Woman's Day (Australia Edition). 8/26/2024, Issue 2433, p24-25. 2p. 5 Color Photographs.

Record details

Banishing Blind Spots.

• Authors : Langreth, Robert

Subjects: RETINAL degeneration treatment; RETINITIS pigmentosa; TREATMENT of eye diseases

• Source: Forbes. 11/13/2006, Vol. 178 Issue 10, p130-131. 2p. 1 Color Photograph, 3 Diagrams.

Record details

Miniature drug factories save failing eyesight.

• Authors : Cohen, Philip

Subjects: RETINITIS pigmentosa; CELLS; THERAPEUTICS

• Source: New Scientist. 1/4/2003, Vol. 177 Issue 2376, p18. 2/3p. 1 Color Photograph.

Record details

John McMurray.

Subjects: MCMURRAY, John; RETINITIS pigmentosa; DIAGNOSIS

• Source: People. 5/2/88, Vol. 29 Issue 17, p8. 1p.

Record details

GenSight's mutation-agnostic gene therapy triggers partial vision recovery.

• Authors : Taylor, Nick Paul (AUTHOR)

Subjects: GENE therapy; RETINITIS pigmentosa; VISION

• Source: FierceBiotech. 5/25/2021, pN.PAG-N.PAG. 1p.

Record details

Biogen reveals gene therapy trial failure as investors remain laser-focused on aducanumab drama.

• Authors : Armstrong, Annalee (AUTHOR)

Subjects: *INVESTORS; GENE therapy; RETINITIS pigmentosa

• Source: FierceBiotech. 5/14/2021, pN.PAG-N.PAG. 1p.

Record details

TURNING A BIONIC EYE ON RETINITIS.

• Authors : Licking, Ellen

Subjects: RETINITIS pigmentosa; VISION; BIONICS

• Source: BusinessWeek. 1/21/2002, Issue 3766, p75-75. 1/4p. 1 Color Photograph.

Record details

SparingVision raises €44.5M to develop mutation-agnostic gene therapy.

• Authors : Taylor, Nick Paul (AUTHOR)

Subjects: GENE therapy; RETINITIS pigmentosa; CLINICAL trialsFRANCE

• Source: FierceBiotech. 10/20/2020, pN.PAG-N.PAG. 1p.

Record details